July 28, 2015 | Updated 5:00am

E-mail Address


Most Popular

Sunday, August 10, 2014, 3:00am

Investing In The Industry

AbbVie-Shire Deal Likely To Strengthen Mass. Biotech Scene

At $54B, Acquisition Is The Largest Of The Year

Mergers are nothing new in the drug development industry, but when two companies with substantial operations locally are involved, it’s worthy of note. In mid-July, drug-maker AbbVie announced it would acquire Shire Pharmaceuticals for $54 billion. It’s the biggest acquisition of the year.

This content is available to subscribers only

A valid subscription is required to read the article or use the tool you've selected. Already a subscriber? Please enter your information below to log in.

Don't have a subscription yet? You're missing out. Subscribing to Banker & Tradesman gives you unlimited access to all of our award winning content and data tools. Interested in subscribing? Click here now to signup for a new account, or activate your web account if you are a new print subscriber.

Forgot Your Password?

Please enter your e-mail address above so we can send you an email which will allow you to reset your password

Sign In

Become a Subscriber For Less Than $1 Per Day

Our subscribers have access to the most current, comprehensive real estate and credit records available for the state of Massachusetts. We are the only body that collects all transaction data from every city and town in the state - and we deliver that vital information via our Records & Research section as fast as we can.

By becoming a subscriber, you will have access to all of our credit and real estate records dating back ten years, searchable by address, name and transaction date. This is valuable intelligence that you can use every week to make decisions and grow your business. Become a subscriber today!

Subscribe to Banker & Tradesman